Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma

von Labriola, Matthew K., Batich, Kristen A., Zhu, Jason, McNamara, Megan A., Harrison, Michael R., Armstrong, Andrew J., George, Daniel J., Zhang, Tian
Veröffentlicht in Clin Genitourin Cancer (2019)

Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma

von Labriola, Matthew Kyle, Zhu, Jason, Gupta, Rajan, McCall, Shannon, Jackson, Jennifer, Kong, Eric F, White, James R, Cerqueira, Gustavo, Gerding, Kelly, Simmons, John K, George, Daniel, Zhang, Tian
Veröffentlicht in J Immunother Cancer (2020)

LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

von Brown, Landon C, Tucker, Matthew D, Sedhom, Ramy, Schwartz, Eric B, Zhu, Jason, Kao, Chester, Labriola, Matthew K, Gupta, Rajan T, Marin, Daniele, Wu, Yuan, Gupta, Santosh, Zhang, Tian, Harrison, Michael R, George, Daniel J, Alva, Ajjai, Antonarakis, Emmanuel S, Armstrong, Andrew J
Veröffentlicht in J Immunother Cancer (2021)

Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients

von Zhang, Tian, Pabla, Sarabjot, Lenzo, Felicia L., Conroy, Jeffrey M., Nesline, Mary K., Glenn, Sean T., Papanicolau-Sengos, Antonios, Burgher, Blake, Giamo, Vincent, Andreas, Jonathan, Wang, Yirong, Bshara, Wiam, Madden, Katherine G., Shirai, Keisuke, Dragnev, Konstantin, Tafe, Laura J., Gupta, Rajan, Zhu, Jason, Labriola, Matthew, McCall, Shannon, George, Daniel J., Ghatalia, Pooja, Dayyani, Farshid, Edwards, Robert, Park, Michelle S, Singh, Rajbir, Jacob, Robin, George, Saby, Xu, Bo, Zibelman, Matthew, Kurzrock, Razelle, Morrison, Carl
Veröffentlicht in Oncoimmunology (2020)

Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors

von Conroy, Jeffrey M., Pabla, Sarabjot, Nesline, Mary K., Glenn, Sean T., Papanicolau-Sengos, Antonios, Burgher, Blake, Andreas, Jonathan, Giamo, Vincent, Wang, Yirong, Lenzo, Felicia L., Bshara, Wiam, Khalil, Maya, Dy, Grace K., Madden, Katherine G., Shirai, Keisuke, Dragnev, Konstantin, Tafe, Laura J., Zhu, Jason, Labriola, Matthew, Marin, Daniele, McCall, Shannon J., Clarke, Jeffrey, George, Daniel J., Zhang, Tian, Zibelman, Matthew, Ghatalia, Pooja, Araujo-Fernandez, Isabel, de la Cruz-Merino, Luis, Singavi, Arun, George, Ben, MacKinnon, Alexander C., Thompson, Jonathan, Singh, Rajbir, Jacob, Robin, Kasuganti, Deepa, Shah, Neel, Day, Roger, Galluzzi, Lorenzo, Gardner, Mark, Morrison, Carl
Veröffentlicht in J Immunother Cancer (2019)

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients

von Pabla, Sarabjot, Conroy, Jeffrey M., Nesline, Mary K., Glenn, Sean T., Papanicolau-Sengos, Antonios, Burgher, Blake, Hagen, Jacob, Giamo, Vincent, Andreas, Jonathan, Lenzo, Felicia L., Yirong, Wang, Dy, Grace K., Yau, Edwin, Early, Amy, Chen, Hongbin, Bshara, Wiam, Madden, Katherine G., Shirai, Keisuke, Dragnev, Konstantin, Tafe, Laura J., Marin, Daniele, Zhu, Jason, Clarke, Jeff, Labriola, Matthew, McCall, Shannon, Zhang, Tian, Zibelman, Matthew, Ghatalia, Pooja, Araujo-Fernandez, Isabel, Singavi, Arun, George, Ben, MacKinnon, Andrew Craig, Thompson, Jonathan, Singh, Rajbir, Jacob, Robin, Dressler, Lynn, Steciuk, Mark, Binns, Oliver, Kasuganti, Deepa, Shah, Neel, Ernstoff, Marc, Odunsi, Kunle, Kurzrock, Razelle, Gardner, Mark, Galluzzi, Lorenzo, Morrison, Carl
Veröffentlicht in J Immunother Cancer (2019)